Joshua C. Bond

Joshua C. Bond is an experienced professional in the biopharmaceutical industry, currently serving as Director of Key Accounts - West at TG Therapeutics, Inc. since November 2021. Previously, Joshua held various positions at Novartis, including Associate Director of Thought Leader Liaison in Multiple Sclerosis and Strategic Account Manager. At Genentech, Joshua worked as a Clinical Specialist, and at Acorda Therapeutics, Inc., Joshua advanced from Area Business Manager to Market Development Manager, focusing on the launch and promotion of Ampyra. Earlier roles included Clinical Sales Consultant at Solstice Neurosciences and Biotech Sales Specialist at MedImmune, where Joshua specialized in reimbursement for pediatric care. Joshua began their career at Elan Pharmaceuticals as a Sales Representative. Joshua holds a Bachelor of Science degree in Technical Sales from Weber State University.